Prospective examination of adrenocortical function in advanced AIDS patients

Endocrine Journal

Volumn 49, Issue 6, 2002, Pages 641-647

  Hoshino, Yoshihiko ^a,b   Yamashita, Naohide ^a   Nakamura, Tetsuya ^a   Iwamoto, Aikichi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CMV (human cytomegalovirus); Cosyntropin stimulation; HIV (human immunodeficiency virus); Sensitivity and specificity; Urinary free cortisol

Indexed keywords

TETRACOSACTIDE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADRENAL CORTEX FUNCTION; ADRENAL INSUFFICIENCY; ARTICLE; HORMONAL REGULATION; HOSPITALIZATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HYDROCORTISONE BLOOD LEVEL; MEDICAL EXAMINATION; PROSPECTIVE STUDY; PROVOCATION TEST; VIRUS DETECTION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; ADRENAL CORTEX FUNCTION TESTS; ADRENAL INSUFFICIENCY; ADRENOCORTICOTROPIC HORMONE; ADULT; CD4 LYMPHOCYTE COUNT; CHILD; CYTOMEGALOVIRUS INFECTIONS; EVALUATION STUDIES; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HIV-1; HORMONE REPLACEMENT THERAPY; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 0347420012     PISSN: 09188959     EISSN: None     Source Type: Journal    
DOI: 10.1507/endocrj.49.641     Document Type: Article

References (18)

1. Torriani FJ, Freeman WR, Macdonald JC, Karavellas MP, Durand DM, Jeffrey DD, Meylan PR, Schrier RD (2000) CMV retinitis recurs after stopping treatment in virological and immunological failure of potent antiretroviral therapy. AIDS 14: 173-180.
2. Jacobson MA, Stanley H, Holtzer C, Margolis TP, Cunninham ET (2000) Natural history and outcome of new AIDS-related cytomegalovirus retinitis diagnosed in the era of highly active antiretroviral therapy. Clini Infects Dis 30: 231-233.
3. Hoshino Y, Yamashita N, Iwamoto A (1998) Adrenal insufficiency in AIDS patients. ACTH Related Peptides 9: 247-252. (in Japanese).
4. Bowen EF, Wilson P, Atkins M, Madge S, Griffiths PD, Johnson MA, Emery VC (1995) Natural history of untreated cytomegalovirus retinitis. Lancet 346: 1671-1673.
5. Freda PU, Wardlaw SL, Brudne K, Goland RS (1994) Primary adrenal insufficiency in patients with the acquired immunodeficiency syndrome: a report of five cases. J Clin Endocrinol and Metab 79: 1540-1545.
6. Hoshino Y, Nagata Y, Gatanaga H, Hosono O, Morimoto C, Tachikawa N, Nomura K, Wakabayashi T, Oka S, Nakamura T, Iwamoto A (1997) Cytomegalovirus (CMV) retinitis and CMV antigenemia as a clue to impaired adrenocortical function in patients with AIDS. AIDS 11: 1719-1724.
7. Mayo J, Collazos J, Martinez E, Ibarra S (2002) Adrenal function in the human immunodeficiency virus-infected patient. Arch Intern Med 162: 1095-1098.
8. Hoshino Y, Nagata Y, Taguchi H, Masunaga A, Fujino Y, Mochizuki M, Nakamura T, Iwamoto A (1999) Role of the cytomegalovirus (CMV)-antigenemia assay as predictive and follow-up detection tool for CMV disease in AIDS patients. Microbiol Immunol 43: 959-965.
9. Pulakhandam U, Dincsoy HP (1990) Cytomegaloviral Adrenalitis and Adrenal Insufficiency in AIDS. Am J Clin Pathol 93: 651-656.
10. Oelkers W (1996) Adrenal insufficiency. N Engl J Med 335: 1206-1212.
11. Sellmeyer DE, Grunfeld C (1996) Endocrine and metabolic disturbances in human immunodeficiency virus infection and the acquired immune deficiency syndrome. Endocr Rev 17: 518-522.
12. Thaler LM, Blevins LS Jr (1998) The low dose (1-μg) adrenocorticotropin stimulation test in the evaluation of patients with suspected central adrenal insufficiency. J Clin Endocrinol Metab 83: 2726-2729.
13. Jacobson MA, Zegans M, Pavan PR, O'Donnell JJ, Sattler F, Rao N, Owens S, Pollard R (1997) Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy. Lancet 349: 1443-1445.
14. Race EM, Adelson-Mitty J, Kriegel GR, Barlam TF, Reimann KA, Letvin NL, Japour AJ (1998) Focal mycobacterial lymphadenitis following initiation of protease-inhibitor therapy in patients with advanced HIV-1 disease. Lancet 351: 252-255.
15. Michelet C, Arvieux C, Francois C (1998) Opportunistic infections occurring during highly active antiretroviral treatment. AIDS 12: 1815-1822.
16. Dube MP, Johnson DL, Currier JS, Leedome JM (1997) Protease inhibitor-associated hyperglycemia. Lancet 350: 713-714.
17. Carr A, Samaras K, Burton S, law M, Freund J, Chisholm DJ, Cooper DA (1998) A syndrome of peripheral lipodystrophy, hyperglycemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS 12: F51-F58.
18. Yanovski JA, Miller KD, Kino T, Freidman TC, Chrousos GP, Tsigos C, Falloon J (1999) Endocrine and metabolic evaluation of human immunodeficiency virus-infected patients with evidence of protease inhibitor-associated lipodystrophy. J Clini Endocrino Metab 84: 1925-1931.